108 related articles for article (PubMed ID: 8823494)
21. Thymidylate synthase level as the main predictive parameter for sensitivity to 5-fluorouracil, but not for folate-based thymidylate synthase inhibitors, in 13 nonselected colon cancer cell lines.
van Triest B; Pinedo HM; van Hensbergen Y; Smid K; Telleman F; Schoenmakers PS; van der Wilt CL; van Laar JA; Noordhuis P; Jansen G; Peters GJ
Clin Cancer Res; 1999 Mar; 5(3):643-54. PubMed ID: 10100718
[TBL] [Abstract][Full Text] [Related]
22. Differential effects of recombinant interferon-alpha and 5-fluorouracil against colon cancer cells or against peripheral blood mononuclear cells.
De Filippi R; Prete SP; Giuliani A; Silvi E; Yamaue H; Nieroda CA; Greiner JW; De Vecchis L; Bonmassar E
Anticancer Res; 1994; 14(5A):1767-73. PubMed ID: 7847809
[TBL] [Abstract][Full Text] [Related]
23. Effect of methotrexate and 1-beta-D-arabinofuranosylcytosine on pools of deoxyribonucleoside triphosphates in L1210 ascites cells.
Roberts D; Peck C
Cancer Res; 1981 Feb; 41(2):505-10. PubMed ID: 7448798
[TBL] [Abstract][Full Text] [Related]
24. Enhanced cytotoxicity with interleukin-1 alpha and 5-fluorouracil in HCT116 colon cancer cells.
Geoffroy FJ; Allegra CJ; Sinha B; Grem JL
Oncol Res; 1994; 6(12):581-91. PubMed ID: 7787251
[TBL] [Abstract][Full Text] [Related]
25. Nucleoside-mediated mitigation of 5-fluorouracil-induced toxicity in synchronized murine erythroleukemic cells.
Elstein KH; Mole ML; Setzer RW; Zucker RM; Kavlock RJ; Rogers JM; Lau C
Toxicol Appl Pharmacol; 1997 Sep; 146(1):29-39. PubMed ID: 9299594
[TBL] [Abstract][Full Text] [Related]
26. Mechanism of acquired 5FU resistance and strategy for overcoming 5FU resistance focusing on 5FU metabolism in colon cancer cell lines.
Suetsugu T; Mori R; Futamura M; Fukada M; Tanaka H; Yasufuku I; Sato Y; Iwata Y; Imai T; Imai H; Tanaka Y; Okumura N; Matsuhashi N; Takahashi T; Yoshida K
Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649846
[TBL] [Abstract][Full Text] [Related]
27. Relationship of deoxynucleotide changes to inhibition of DNA synthesis induced by the antiretroviral agent 3'-azido-3'-deoxythymidine and release of its monophosphate by human lymphoid cells (CCRF-CEM).
Fridland A; Connelly MC; Ashmun R
Mol Pharmacol; 1990 May; 37(5):665-70. PubMed ID: 2338944
[TBL] [Abstract][Full Text] [Related]
28. Interferons as biomodulators of fluoropyrimidines in the treatment of colorectal cancer.
Makower D; Wadler S
Semin Oncol; 1999 Dec; 26(6):663-71. PubMed ID: 10606259
[TBL] [Abstract][Full Text] [Related]
29. Mechanisms involved in the potentiation of paclitaxel or 5-fU by the hypoxic cytotoxin NLCQ-1 (NSC 709257) in vitro.
Papadopoulou MV; Ji X; Bloomer WD
Anticancer Res; 2005; 25(3B):2161-70. PubMed ID: 16158959
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of ribonucleoside and deoxyribonucleoside triphosphate pools in cultured leukemia cells during exposure to methotrexate or methotrexate plus thymidine.
Kinahan JJ; Otten M; Grindey GB
Cancer Res; 1979 Sep; 39(9):3531-9. PubMed ID: 476679
[TBL] [Abstract][Full Text] [Related]
31. Interference of gemcitabine triphosphate with the measurements of deoxynucleotides using an optimized DNA polymerase elongation assay.
Smid K; Van Moorsel CJ; Noordhuis P; Voorn DA; Peters GJ
Int J Oncol; 2001 Jul; 19(1):157-62. PubMed ID: 11408937
[TBL] [Abstract][Full Text] [Related]
32. Elevation of thymidylate synthase following 5-fluorouracil treatment is prevented by the addition of leucovorin in murine colon tumors.
Van der Wilt CL; Pinedo HM; Smid K; Peters GJ
Cancer Res; 1992 Sep; 52(18):4922-8. PubMed ID: 1516048
[TBL] [Abstract][Full Text] [Related]
33. Effects of perturbations of pools of deoxyribonucleoside triphosphates on expression of ribonucleotide reductase, a G1/S transition state enzyme, in p53-mutated cells.
Wadler S; Horowitz R; Zhang HY; Schwartz EL
Biochem Pharmacol; 1998 May; 55(9):1353-60. PubMed ID: 10076525
[TBL] [Abstract][Full Text] [Related]
34. Cytotoxicity and DNA fragmentation associated with sequential gemcitabine and 5-fluoro-2'-deoxyuridine in HT-29 colon cancer cells.
Ren Q; Kao V; Grem JL
Clin Cancer Res; 1998 Nov; 4(11):2811-8. PubMed ID: 9829747
[TBL] [Abstract][Full Text] [Related]
35. Recombinant human interferon alpha-2a increases 5-fluorouracil efficacy by elevating fluorouridine concentration in tumor tissue.
Kase S; Kubota T; Watanabe M; Teramoto T; Kitajima M; Hoffman RM
Anticancer Res; 1994; 14(3A):1155-9. PubMed ID: 8074466
[TBL] [Abstract][Full Text] [Related]
36. Azidothymidine in combination with 5-fluorouracil in human colorectal cell lines: in vitro synergistic cytotoxicity and DNA-induced strand-breaks.
Andreuccetti M; Allegrini G; Antonuzzo A; Malvaldi G; Conte PF; Danesi R; Del Tacca M; Falcone A
Eur J Cancer; 1996 Jun; 32A(7):1219-26. PubMed ID: 8758257
[TBL] [Abstract][Full Text] [Related]
37. Diverse deoxyribonucleotide profiles in cultured human cells with differential sensitivity to thymidine.
Leyva A; Appel H; Pinedo HM
Cancer Biochem Biophys; 1984 Sep; 7(3):231-7. PubMed ID: 6333268
[TBL] [Abstract][Full Text] [Related]
38. IFN gamma-induced up-regulation of PD-ECGF/TP enhances the cytotoxicity of 5-fluorouracil and 5'-deoxy-5-fluorouridine in bladder cancer cells.
Li G; Kawakami S; Kageyama Y; Yan C; Saito K; Kihara K
Anticancer Res; 2002; 22(5):2607-12. PubMed ID: 12529971
[TBL] [Abstract][Full Text] [Related]
39. Effect of hydroxyurea and 5-fluorodeoxyuridine on deoxyribonucleoside triphosphate pools early in phytohemagglutinin-stimulated human lymphocytes.
Tyrsted G
Biochem Pharmacol; 1982 Oct; 31(19):3107-13. PubMed ID: 6216891
[TBL] [Abstract][Full Text] [Related]
40. Azidothymidine-induced cytotoxicity and incorporation into DNA in the human colon tumor cell line HCT-8 is enhanced by methotrexate in vitro and in vivo.
Tosi P; Calabresi P; Goulette FA; Renaud CA; Darnowski JW
Cancer Res; 1992 Aug; 52(15):4069-73. PubMed ID: 1638518
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
